Compare DexCom, Inc. (DXCM) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Manulife Financial Corporation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Manulife Financial Corporation trades at $43.84 (market cap $72.68B). The key difference: Manulife Financial Corporation is far larger — about 2.2× DexCom, Inc.'s market cap, and Manulife Financial Corporation pays a 3.1% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | MFC | |
|---|---|---|
Market Cap | $33.79B | $72.68B |
Sector | Health | Financials |
52-Week High | $89.53 | $44.77 |
52-Week Low | $54.84 | $30.06 |
Enterprise Value | $33.24B | $67.84B |
Dividend Yield | — | 3.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
